Natus Medical Research and Development Expense Trend

Natus Medical Incorporated -- USA Stock  

USD 28.65  0.4  1.42%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 194, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 32.5157. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Research and Development Expense of Natus Medical Incorporated with missing and latest data points interpolated. A component of Operating Expenses representing the aggregate costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service.
Research and Development Expense  10 Years Trend  
Slightly volatile
 Research and Development Expense 

Natus Medical Research and Development Expense Over Time

2016-12-31  33,443,000 
2017-12-31  33,443,000 
2018-12-31  33,619,474 

Other Fundumenentals


Regression Statistics

Arithmetic Mean  24,679,113
Geometric Mean  22,105,099
Coefficient Of Variation  37.33
Mean Deviation  7,682,856
Median  29,966,000
Standard Deviation  9,212,193
Range  29,337,474
R Value  0.93
R Squared  0.87
Significance  0.00000393
Slope  2,201,444

Currently Trending

Purchased over 100 shares of
few hours ago ago
Traded for 76.42
Purchased over 90 shares of
few hours ago ago
Traded for 20.03
Purchased over 200 shares of
few hours ago ago
Traded for 12.0